PropertyValue
?:abstract
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been recently linked to dermatologic manifestations and is thought to affect more severely patients with androgenetic alopecia. We designed a prospective multicentric study which enrolled patients from March to August of 2020 with acute telogen effluvium (ATE) that had a prior SARS-CoV-2 infection confirmed either by serological tests (e.g. detection of serum antibodies against the virus via enzyme-linked immunosorbent assays (ELISA)) or detection of viral RNA using real-time reverse transcription polymerase chain reaction (RT-PCR).
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1111/jdv.17045
?:journal
  • J_Eur_Acad_Dermatol_Venereol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/f2b8e6f6975029bc610bdf9e0a2fdfc0cfb1e6ff.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7753386.xml.json
?:pmcid
?:pmid
?:pmid
  • 33220124.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
?:type
?:year
  • 2020-12-09

Metadata

Anon_0  
expand all